About
Age-related mobility decline and conditions like sarcopenia are often linked to the deterioration of neuron-muscle communication. Juvion Life Sciences (JLS), a spin-off from EPFL, has identified innovative biological mechanisms that preserve neuromuscular connections, maintaining the structure and function of motor circuitry. This breakthrough is pivotal, demonstrating for the first time that mobility decline can be mitigated.
Building on this expertise, Juvion integrates cutting-edge, sustainable, first-in-class discovery platforms to develop safe and effective therapeutics aimed at stabilizing the motor system and combating mobility loss. Their mission is to make these solutions accessible to all aging individuals, addressing a critical societal challenge as the global population continues to grow older.
Sectors